down arrow

Evoq Remedies

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE0JVD01011
  • NSEID:
  • BSEID: 543500
INR
2.86
0.05 (1.78%)
BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 4000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Evoq Remedies Ltd stock-summary
stock-summary
Evoq Remedies Ltd
Micro Cap
Pharmaceuticals & Drugs
Evoq Remedies Limited was originally incorporated as "Salus Life Science and Research Private Limited" at Ahmedabad, Gujarat on February 24th, 2010 vide Certificate of Incorporation issued by Assistant Registrar of Companies, Gujarat, Dadra and Nagar Haveli. Subsequently, name of the Company was changed to "Evoq Remedies Private Limited" on July 15th, 2019 with Certificate of Incorporation pursuant to change of name issued by Registrar of Companies, Ahmedabad.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 24.90 Cr
Number of Shares
2.49 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
22-Jun-2024
2.49
24.90
11300000
10
Preferential basis
28-Mar-2022
1.36
13.60
3600000
10
Public Issue
28-Mar-2022
1.36
13.60
3600000
10
Public Issue
25-Mar-2022
1.36
13.60
3600000
10
Public Issue
05-Feb-2022
1
10.00
645000
10
Preferential basis
03-Feb-2022
93.55
9.36
645000
10
Preferential basis
03-Jan-2022
87.1
8.71
8000000
10
Preferential Allotment
20-Dec-2021
7.1
0.71
700000
10
Bonus Issue
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Patel Payal Bhumishth (6.02%)

Highest Public shareholder

Dhruv Ganji (11.35%)

Individual Investors Holdings

85.75%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 7 Cr (Micro Cap)

stock-summary
P/E

7.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.16

stock-summary
Return on Equity

1.78%

stock-summary
Price to Book

0.28